Inicio>>Signaling Pathways>> Immunology/Inflammation>> STING>>diABZI-C2-NH2

diABZI-C2-NH2

Catalog No.GC63473

diABZI-C2-NH2, un anÁlogo activo que contiene una funcionalidad de amina primaria, es un agonista de STING.

Products are for research use only. Not for human use. We do not sell to patients.

diABZI-C2-NH2 Chemical Structure

Cas No.: 2137975-93-8

Tamaño Precio Disponibilidad Cantidad
5 mg
702,00 $
Disponible
10 mg
1.125,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

diABZI-C2-NH2, an active analogue containing a primary amine functionality, is a STING agonist[1].

The author developed a linking strategy to synergize the effect of two symmetry-related amidobenzimidazole (ABZI)-based compounds to create linked ABZIs (diABZIs) with enhanced binding to STING and cellular function. Intravenous administration of a diABZI STING agonist to immunocompetent mice with established syngeneic colon tumours elicited strong anti-tumour activity, with complete and lasting regression of tumors[1]. diABZI-C2-NH2 is covalently immobilized on sepharose beads and is used to affinity-capture potential target proteins from a THP1 cell lysate[1].

[1]. Ramanjulu JM, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity [published correction appears in Nature. 2019 Jun;570(7761):E53]. Nature. 2018;564(7736):439-443.

Reseñas

Review for diABZI-C2-NH2

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for diABZI-C2-NH2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.